Skip to Content

Join the 'MyOxin' group to help and get support from people like you.

MyOxin News

Teething Tips From Dental Specialists

Posted 1 day 15 hours ago by Drugs.com

Friday, Dec. 9, 2016 – You've fed your baby, changed your baby, but the baby is still cranky. It's possible he or she is uncomfortable because tiny teeth are trying to push through the gums. What can you do to ease the pain? One approach is to offer a plain, solid teething ring, which lets the baby apply pressure to ease the pain. While chilling the teething ring may provide added relief, don't freeze it because the extreme cold can be harmful rather than soothing, dental experts say. "Your child's gums can be sensitive during this time, and your child will know how much pressure they should apply to try and relieve the pain. They're their best teacher and, in this instance, know what they need," said Dr. William Wathen, associate professor at Texas A&M University's College of Dentistry. Massaging a baby's gums with a clean finger or a cooled washcloth is also soothing. If you've ... Read more

Related support groups: Oral and Dental Conditions, Toothache, Maintain, Orajel, Benzocaine, Anbesol, Vagisil, Lanacane, Allergen, Zilactin Toothache, Antipyrine/Benzocaine, Solarcaine, Dendracin, Cough-X Cough Relief, A/B Otic, Anbesol Gel, Orabase Baby Teething Gel, Boil Ease Pain Relieving, Play Longer, Kank-a

FDA Medwatch Alert: Unapproved Prescription Ear Drop (Otic) Products: Not FDA Evaluated for Safety, Effectiveness and Quality

Posted 1 Jul 2015 by Drugs.com

ISSUE: FDA announced its intention to take enforcement action against companies that manufacture and/or distribute certain unapproved prescription ear drop products (known as otic products) labeled to relieve ear pain, infection, and inflammation. The unapproved prescription ear drops contain active ingredients such as benzocaine and hydrocortisone, and have not been evaluated by the FDA for safety, effectiveness and quality. The labels on these products do not disclose that they lack FDA approval, and health care professionals may not be aware of their unapproved status. Unapproved prescription otic drug products are frequently given to young children suffering from ear infections and other conditions that cause ear pain and swelling. Patients taking unapproved drugs may be at greater risk because there is no proven safety or effectiveness information. These products may be ... Read more

Related support groups: Otitis Media, Benzocaine, Ear Conditions, Allergen, Otitis Externa, Antipyrine/Benzocaine, A/B Otic, Chronic Otitis Media, Trioxin, Tri-Otic, Neotic, Benzocaine/Chloroxylenol/Hydrocortisone, Oticaine, Cortane-B, Cortane-B Otic, Pramotic, Otigesic, Cyotic, Aurodex, Otirx

FDA Takes Action Against Unapproved Prescription Ear Drop Products

Posted 1 Jul 2015 by Drugs.com

July 1, 2015 – The U.S. Food and Drug Administration today announced its intention to take enforcement action against companies that manufacture and/or distribute certain unapproved prescription ear drop products (known as otic products) labeled to relieve ear pain, infection, and inflammation. The unapproved prescription ear drops contain active ingredients such as benzocaine and hydrocortisone, and have not been evaluated by the FDA for safety, effectiveness and quality. The labels on these products do not disclose that they lack FDA approval, and health care professionals may not be aware of their unapproved status. In a federal register notice published today, the agency informed the companies that they must stop manufacturing these unapproved prescription otic products or be subject to enforcement actions, including seizure, injunction and/or criminal proceedings. Today’s action ... Read more

Related support groups: Benzocaine, Ear Conditions, Allergen, Antipyrine/Benzocaine, A/B Otic, Tri-Otic, Trioxin, Neotic, Oticaine, Benzocaine/Chloroxylenol/Hydrocortisone, Cortane-B, Cortane-B Otic, Pramotic, Aurogard, Otigesic, Chloroxylenol/Hydrocortisone/Pramoxine, Cyotic, Oticin, Aurodex, Otirx

Unapproved Ear Drops Targeted by FDA

Posted 1 Jul 2015 by Drugs.com

WEDNESDAY, July 1, 2015 – The prescription drops your child is using for ear pain could be among 16 unapproved medications targeted this week by the U.S. Food and Drug Administration. These drugs, prescribed and sold for years to relieve ear pain and swelling, have not been evaluated for safety, quality and effectiveness, the agency said Wednesday. The agency notified the drugs' makers to stop marketing the drops following a few reports of local allergic reactions of the ear, eye, face, neck and mouth. The drops can also cause itching, stinging, burning and irritation of the ear, according to an FDA news release. "If we don't know whether these drugs have any benefits, we should not accept any possible risk of side effects," said the FDA's Dr. Charles Lee in the news release. The FDA did not release the names of the companies or the medications involved, but did note that "unapproved ... Read more

Related support groups: Otitis Media, Maintain, Orajel, Benzocaine, Pramoxine, Anbesol, Anusol, Vagisil, Lanacane, Allergen, Caladryl, Galzin, Analpram-HC, Antipyrine/Benzocaine, Dendracin, Caladryl Clear, Zilactin Toothache, Hydrocortisone/Pramoxine, Otitis Externa, Solarcaine

Ask a Question

Further Information

Related Condition Support Groups

Otitis Externa

MyOxin Patient Information at Drugs.com